Outset Medical (OM) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Precision Optics (POCI) has outperformed Outset Medical (OM) over the past year, losing 10.4% versus a loss of 34.5%. Over five years, POCI leads with a -37.9% price change compared with -99.6% for OM. Outset Medical is the larger company by market cap ($53.0 million vs $45.3 million), about 1.2 times the size, while Precision Optics is growing revenue faster (+65.2% vs +5.1%).
Precision Optics converts more of its revenue into profit, with a net margin of -11.5% versus -68.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OM | POCI |
|---|---|---|
| Share price | $2.81 | $4.12 |
| Market cap | $53.03M | $45.30M |
| 1-day change | -3.44% | +1.41% |
| YTD return | -24.26% | -1.67% |
| 1-year return | -34.50% | -10.43% |
| 5-year return | -99.61% | -37.86% |
| Forward P/E | — | 206.00 |
| EPS (TTM) | $-3.78 | $-0.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $119.48M | $31.53M |
| Revenue growth (YoY) | +5.09% | +65.16% |
| Net income (latest FY) | $-81.65M | $-3.63M |
| Gross margin | 39.13% | 17.22% |
| Operating margin | -55.83% | -11.13% |
| Net margin | -68.34% | -11.51% |
| 52-week high | $6.49 | $6.15 |
| 52-week low | $2.77 | $3.55 |
| Distance from 52-week high | -56.70% | -33.01% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +172.95% | +94.17% |
| Average volume | 140.40K | 43.00K |
| Shares outstanding | 18.87M | 10.99M |
| Employees | 310 | 108 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- POCI has outperformed OM by 24.1 percentage points over the past year.
- Precision Optics is more profitable, keeping -11.5 cents of every revenue dollar as net income versus -68.3 cents for Outset Medical.
- Precision Optics grew revenue faster in its latest fiscal year (+65.16% vs +5.09%).
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
OM vs POCI FAQ
Which is bigger, Outset Medical or Precision Optics?
Outset Medical (OM) is larger, with a market capitalization of $53.03M compared with $45.30M for Precision Optics (POCI).
Which stock has performed better over the past year, OM or POCI?
POCI returned -10.43% over the past 12 months, compared with -34.50% for OM (price return, excluding dividends). Past performance does not predict future results.
Are Outset Medical and Precision Optics in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.